https://www.clinicaltrialsarena.com/news/structure-therapeutics-aleniglipron-trial/?utm_source=tldrbio.tech&utm_medium=referral&utm_campaign=biotech-pharma-updates-december-7-8-2025
Structure Therapeutics has reported positive topline results from the ACCESS clinical programme for its investigational oral GLP-1 receptor agonist,...
positive resultsstructuretherapeuticsannouncesaleniglipron